國家衛生研究院 NHRI:Item 3990099045/12667

NHRI > Institute of Biotechnology and Pharmaceutical Research > Jyh-Haur Chern > Periodical Articles > Item 3990099045/12667

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/12667

Title:	Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors
Authors:	Hsieh, CF;Jheng, JR;Lin, GH;Chen, YL;Ho, JY;Liu, CJ;Hsu, KY;Chen, YS;Chan, YF;Yu, HM;Hsieh, PW;Chern, JH;Horng, JT
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	Enterovirus A71 (EV-A71), a positive-stranded RNA virus of the Picornaviridae family, may cause neurological complications or fatality in children. We examined specific factors responsible for this virulence using a chemical genetics approach. Known compounds from an anti-EV-A71 herbal medicine, Salvia miltiorrhiza (Danshen), were screened for anti-EV-A71. We identified a natural product, rosmarinic acid (RA), as a potential inhibitor of EV-A71 by cell-based antiviral assay and in vivo mouse model. Results also show that RA may affect the early stage of viral infection and may target viral particles directly, thereby interfering with virus-P-selectin glycoprotein ligand-1 (PSGL1) and virus-heparan sulfate interactions without abolishing the interaction between the virus and scavenger receptor B2 (SCARB2). Sequencing of the plaque-purified RA-resistant viruses revealed a N104 K mutation in the five-fold axis of the structural protein VP1, which contains positively charged amino acids reportedly associated with virus-PSGL1 and virus-heparan sulfate interactions via electrostatic attraction. The plasmid-derived recombinant virus harbouring this mutation was confirmed to be refractory to RA inhibition. Receptor pull-down showed that this non-positively charged VP1-N104 is critical for virus binding to heparan sulfate. As the VP1-N104 residue is conserved among different EV-A71 strains, RA may be useful for inhibiting EV-A71 infection, even for emergent virus variants. Our study provides insight into the molecular mechanism of virus-host interactions and identifies a promising new class of inhibitors based on its antiviral activity and broad spectrum effects against a range of EV-A71.
Date:	2020-12
Relation:	Emerging Microbes and Infections. 2020 Dec;9(1):1194-1205.
Link to:	http://dx.doi.org/10.1080/22221751.2020.1767512
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2222-1751&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000563520300001
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85086051554
Appears in Collections:	[陳志豪] 期刊論文

Files in This Item:

File	Description	Size	Format
PUB32397909.pdf		1383Kb	Adobe PDF	283	View/Open

Loading...